Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7151383 | 1.00 | LMNA (0.44) | LMNAALDH1A1TDP1TSHRTHRB | |
| SCHEMBL7150167 | 1.00 | LMNA (0.44) | LMNAALDH1A1TDP1TSHRTHRB | |
| SCHEMBL7151040 | 1.00 | LMNA (0.44) | LMNAALDH1A1TDP1TSHRTHRB | |
| SCHEMBL7595607 | 1.00 | LMNA (0.44) | LMNAALDH1A1TDP1TSHRTHRB | |
| SCHEMBL5919483 | 1.00 | LMNA (0.44) | LMNAALDH1A1TDP1TSHRTHRB | |
| Propylene Glycol SCHEMBL4753423 | 0.95 | TDP1 (0.53) | LMNAALDH1A1TDP1TSHRTHRB | |
| SCHEMBL16556818 | 0.83 | LMNA (0.40) | LMNAALDH1A1TDP1TSHRTHRB | |
| SCHEMBL14432954 | 0.83 | LMNA (0.40) | LMNAALDH1A1TDP1TSHRTHRB | |
| SCHEMBL31544633 | 0.82 | LMNA (0.44) | LMNAALDH1A1TDP1TSHRTHRB | |
| SCHEMBL19619947 | 0.81 | LMNA (0.41) | LMNAALDH1A1TDP1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-20190309289-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2019-10-10 | — | — | US | disclosed |
| US-10370654-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180320170-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2018-11-08 | — | — | US | disclosed |
| US-9944925-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. | 2018-04-17 | — | — | US | disclosed |
| US-9616139-B2 | Conjugating amines | THE GENERAL HOSPITAL CORPORATION (US) | 2017-04-11 | — | — | US | disclosed |
| US-20160186168-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2016-06-30 | — | — | US | disclosed |
| US-20150031863-A1 | CONJUGATING AMINES | THE GENERAL HOSPITAL CORPORATION (US) | 2015-01-29 | — | — | US | disclosed |
| WO-2013009826-A9 | CONJUGATING AMINES | THE GENERAL HOSPITAL CORPORATION (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013009826-A1 | CONJUGATING AMINES | THE GENERAL HOSPITAL CORPORATION (US) | 2013-01-17 | — | — | WO | disclosed |
| US-5686256-A | TYVELOSE-CONTAINING DISACCHARIDE OR OLIGOSACCHARIDE BINDS WITH ANTIBODY TO FORM COMPLEX | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0682527-A4 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS. | UNIV COLORADO STATE RES FOUND (US) | 1997-05-21 | — | — | EP | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| WO-1996030044-A1 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1996-10-03 | — | — | WO | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| US-5541075-A | DISACCHARIDES, OLIGOSACCHARIDES | HESKA CORPORATION (US) | 1996-07-30 | — | — | US | disclosed |
| EP-0682527-A1 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1995-11-22 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
| WO-1994017824-A1 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1994-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031863-A1 | CONJUGATING AMINES | CD47, CD58, CD44 | LMNA 2936/4885ALDH1A1 3665/4885TDP1 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.